206
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Hierarchical virtual screening: identification of potential high-affinity and selective β3-adrenergic receptor agonists

&
Pages 389-407 | Received 26 Aug 2011, Accepted 04 Nov 2011, Published online: 27 Mar 2012

References

  • Ursino , MG , Vasinaa , V , Raschia , E , Cremab , F and Pontia , FD . 2009 . The β3-adrenoceptor as a therapeutic target: Current perspectives . Pharmacol. Res. , 59 : 221 – 234 .
  • Arch , JRS , Ainsworth , AT , Cawthorne , MA , Piercy , V , Sennitt , MV , Thody , VE , Wilson , C and Wilson , S . 1984 . Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs . Nature , 309 : 163 – 165 .
  • Hu , B and Jennings , LL . 2003 . Orally bioavailable β3-adrenergic receptor agonists as potential therapeutic agents for obesity and type-II diabetes . Prog. Med. Chem. , 41 : 167 – 194 .
  • Shakya , N , Roy , KK and Saxena , AK . 2009 . Substituted 1, 2, 3, 4-tetrahydroquinolin-6-yloxypropanes as β3-adrenergic receptor agonists: Design, synthesis, biological evaluation and pharmacophore modelling . Bioorg. Med. Chem. , 17 : 830 – 847 .
  • Roy , KK and Saxena , AK . 2011 . Structural basis for the β-adrenergic receptor subtype selectivity of the representative agonists and antagonists . J. Chem. Inf. Model. , 51 : 1405 – 1422 .
  • Rosenbaum , DM , Rasmussen , SG and Kobilka , BK . 2009 . The structure and function of G-protein-coupled receptors . Nature , 459 : 356 – 363 .
  • Geppert , H , Vogt , M and Bajorath , J . 2010 . Current trends in ligand-based virtual screening: Molecular representations, data mining methods, new application areas, and performance evaluation . J. Chem. Inf. Model. , 50 : 205 – 216 .
  • Chaudhaery , SS , Roy , KK , Shakya , N , Saxena , G , Sammi , SR , Nazir , A , Nath , C and Saxena , AK . 2010 . Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: Pharmacophore-based virtual screening, synthesis and pharmacology . J. Med. Chem. , 53 : 6490 – 6505 .
  • Ripphausen , P , Nisius , B , Peltason , L and Bajorath , J . 2010 . Quo vadis, virtual screening? A comprehensive survey of prospective applications . J. Med. Chem. , 53 : 8461 – 8467 .
  • Roy , KK , Singh , S and Saxena , AK . 2011 . Integration-mediated prediction enrichment of quantitative model for Hsp90 inhibitors as anti-cancer agents: 3D-QSAR study . Mol. Divers. , 15 : 477 – 489 .
  • Gupta , AK , Bhunia , SS , Balaramnavar , VM and Saxena , AK . 2011 . Pharmacophore modelling, molecular docking and virtual screening for EGFR (HER 1) tyrosine kinase inhibitors . SAR QSAR Env. Res. , 22 : 239 – 263 .
  • Saxena , S , Chaudhaery , SS , Varshney , K and Saxena , AK . 2010 . Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors . SAR QSAR Env. Res. , 21 : 445 – 462 .
  • Saxena , AK , Saxena , S and Chaudhaery , SS . 2010 . Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors . SAR QSAR Env. Res. , 21 : 1 – 20 .
  • Sun , H . 2008 . Pharmacophore-based virtual screening . Curr. Med. Chem. , 15 : 1018 – 1024 .
  • Nicolotti , O , Miscioscia , TF , Carotti , A , Leonetti , F and Carotti , A . 2008 . An integrated approach to ligand- and structure-based drug design: Development and application to a series of serine protease inhibitors . J. Chem. Inf. Model. , 48 : 1211 – 1226 .
  • Knox , AJS , Price , T , Pawlak , M , Golfis , G , Flood , CT , Fayne , D , Williams , DC , Meegan , MJ and Lloyd , DJ . 2009 . Integration of ligand and structure-based virtual screening for the identification of the first dual targeting agent for heat shock protein 90 (Hsp90) and tubulin . J. Med. Chem. , 52 : 2177 – 2180 .
  • Prathipati , P and Saxena , AK . 2005 . Characterization of β3 adrenergic receptor: Determination of pharmacophore and 3D QSAR model for β3 adrenergic receptor agonism . J. Comput. Aided Mol. Des. , 19 : 93 – 110 .
  • Jin , F , Lu , C , Sun , X , Li , W , Liu , G and Tang , Y . Insights into the binding modes of human β3-adrenergic receptor agonists with ligand-based and receptor-based methods, Mol. Divers. 15 (2011), pp. 817–831
  • Imanishi , M , Tomishima , Y , Itou , S , Hamashima , H , Nakajima , Y , Washizuka , K , Sakurai , M , Matsui , S , Imamura , E , Ueshima , K , Yamamoto , T , Yamamoto , N , Ishikawa , H , Nakano , K , Unami , N , Hamada , K , Matsumura , Y , Takamura , F and Hattori , K . 2008 . Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human β3-adrenergic receptor agonists with good oral bioavailability. Part I . J. Med. Chem. , 51 : 1925 – 1944 .
  • Imanishi , M , Nakajima , Y , Tomishima , Y , Hamashima , H , Washizuka , K , Sakurai , M , Matsui , S , Imamura , E , Ueshima , K , Yamamoto , T , Yamamoto , N , Ishikawa , H , Nakano , K , Unami , N , Hamada , K , Matsumura , Y , Takamura , F and Hattori , K . 2008 . Discovery of a novel series of benzoic acid derivatives as potent and selective human β3 adrenergic receptor agonists with good oral bioavailability. 3. Phenylethanolaminotetraline (PEAT) skeleton containing biphenyl or biphenyl ether moiety . J. Med. Chem. , 51 : 4804 – 4822 .
  • Imanishi , M , Itou , S , Washizuka , K , Hamashima , H , Nakajima , Y , Araki , T , Tomishima , Y , Sakurai , M , Matsui , S , Imamura , E , Ueshima , K , Yamamoto , T , Yamamoto , N , Ishikawa , H , Nakano , K , Unami , N , Hamada , K , Matsumura , Y , Takamura , F and Hattori , K . 2008 . Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human β3-adrenergic receptor agonists with good oral bioavailability. Part II . J. Med. Chem. , 51 : 4002 – 4020 .
  • Hattori , K , Toda , S , Imanishi , M , Itou , S , Nakajima , Y , Washizuka , K , Araki , T , Hamashima , H , Tomishima , Y , Sakurai , M , Matsui , S , Imamura , E , Ueshima , K , Yamamoto , T , Yamamoto , N , Ishikawa , H , Nakano , K , Unami , N , Hamada , K , Matsumura , Y and Takamura , F . 2009 . Discovery of highly potent and selective biphenylacylsulfonamide-based β3-adrenergic receptor agonists and evaluation of physical properties as potential overactive bladder therapies: Part 5 . J. Med. Chem. , 52 : 3063 – 3072 .
  • Nakajima , Y , Imanishi , M , Itou , S , Hamashima , H , Tomishima , Y , Washizuka , K , Sakurai , M , Matsui , S , Imamura , E , Ueshima , K , Yamamoto , T , Yamamoto , N , Ishikawa , H , Nakano , K , Unami , N , Hamada , K and Hattori , K . 2008 . Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human β3-adrenergic receptor agonists: Part IV . Bioorg. Med. Chem. Lett. , 18 : 5037 – 5040 .
  • Accelrys Discovery Studio, version 2.0; Accelrys Inc., San Diego, CA, 2007. http://www.accelrys.com
  • Kurogi , Y and Güner , OF . 2001 . Pharmacophore modelling and three-dimensional database searching for drug design using catalyst . Curr. Med. Chem. , 8 : 1035 – 1055 .
  • P.W. Sprague, Automated chemical hypothesis generation and database searching with catalyst, in Perspectives in Drug Discovery and Design, K. Müller, ed., ESCOM Science Publishers BV, Leiden, Netherlands, 1995
  • J. Sutter, O.F. Güner, R. Hoffman, H. Li, and M. Waldman, Effect of variable weight and tolerances on predictive model generation, in Pharmacophore Perception, Development, and use in Drug Design, O.F. Güner, ed., International University Line, La Jolla, CA, 1999
  • CombiGlide, version 2.5; Schrödinger, LLC, New York, 2009. http://www.schrodinger.com
  • Schrödinger, version 8.0; Schrödinger, LLC, New York, 2005. http://www.schrodinger.com
  • Glide, version 5.0; Schrödinger: LLC, New York, 2008. http://www.schrodinger.com
  • Ballesteros , JA and Weinstein , H . 1995 . Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G-protein coupled receptors . Methods Neurosci. , 25 : 366 – 428 .
  • The PyMOL Molecular Graphics System, version 1.3r1; Schrödinger, LLC, Portland, OR, 2010 http://www.schrodinger.com

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.